News

During his 2015 State of the Union address, then-President Barack Obama announced what he promised would be an ambitious public health project. “Tonight, I’m launching a new Precision Medicine Initiative to bring us closer to curing diseases like cancer and diabetes...

This is the 15th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. You can read the first part here. The series...

Justin Schleede reaches onto a black lab bench to pick up a tray of small plastic tubes.

"These are saliva...

"If proven to be safe, we believe preventive gene editing could be one of the most important health technologies of...

By Carl O'Brien, Irish Times | 11.19.2011
AT LEAST 15 children born through surrogacy to Irish couples abroad are caught in a legal limbo which has left...
By Sharon Kirkey, Postmedia News, Montreal Gazette | 11.17.2011
The growing numbers of women postponing motherhood are placing too much blind faith in science to help them conceive when...
By Sharon Kirkey, Postmedia News, Montreal Gazette | 11.17.2011
The growing numbers of women postponing motherhood are placing too much blind faith in science to help them conceive when...
By Osagie K. Obasagie, The American Prospect | 11.17.2011

In 2010, Rebecca Skloot published The Immortal Life of Henrietta Lacks, a New York Times bestseller about a poor...

By Osagie K. Obasagie, The American Prospect | 11.17.2011

In 2010, Rebecca Skloot published The Immortal Life of Henrietta Lacks, a New York Times bestseller about a poor...

By Stephanie O'Neill, The Madeleine Brand Show | 11.16.2011
Stem cell research is expensive. But advocates say it will one day yield cures that could save Americans billions in...
By Stephanie O'Neill, The Madeleine Brand Show | 11.16.2011
Stem cell research is expensive. But advocates say it will one day yield cures that could save Americans billions in...
By Pete Shanks | 11.16.2011

Geron has quit on embryonic stem cells. The company is abandoning its world-leading clinical trial, aimed at using stem cells...